Vaccines

Vaccines features

• 

  What about a vaccine?

  There are two ultimate solutions to HIV: a cure and a vaccine. We cover research towards a cure in this issue. But how is the search for...

  From:HIV treatment update

• 

  Can we create ‘elite controllers’?

  Is combination immunotherapy the future? ask Edwin J Bernard and Derek Thaczuk ...

  From:HIV treatment update

Vaccines news from aidsmap

• Superinfection: second HIV infections happen as often as first ones

  Two studies of people with HIV in Rakai, Uganda and Mombasa, Kenya presented at the 19th Conference on Retroviruses and Opportunistic Infections show that the rate at which they acquired second, subsequent strains of HIV was about the same ...

  10 March 2012 | Gus Cairns

• US CDC recommends HPV vaccine for young men

  Young men and adolescent boys between the ages of 11 and 21 should be vaccinated against human papillomavirus, the cause of genital warts, anal and cervical cancer, the Advisory Committee on Immunization Practices has recommended, in a new Adult ...

  06 February 2012 | Keith Alcorn

• Vaccine provides strong protection against HIV-like infection in monkeys

  A new vaccine approach provided monkeys with a high level of protection against a virulent form of SIV, the monkey equivalent of HIV. Vaccine researchers say the findings are promising, and provide important pointers on how to design an ...

  06 January 2012 | Keith Alcorn

• New vaccine against pneumococcal disease approved for UK

   A new vaccine that may be more suitable for preventing pneumococcal disease in people living with HIV has been approved in the United Kingdom. Prevenar 13, manufactured by Pfizer, is targeted at 13 variants of Streptococcus pneumoniae. Recently published research ...

  30 November 2011 | Keith Alcorn

• Immunisation doesn't prevent mother-to-child HIV transmissions, but approach should not be abandoned, says expert

  An experimental immunisation does not confer any addition protection against mother-to-child transmission of HIV compared to single-dose nevirapine, investigators report in the December 1st edition of the Journal of Acquired Immune Deficiency Syndromes.    The phase III, randomised study was conducted ...

  15 November 2011 | Michael Carter

• HIV vaccine technologists edge nearer to effective designs

  A vaccine symposium held at the sixth International AIDS Society conference (IAS 2011) in Rome heard how designers are slowly developing HIV vaccines designed to overcome problems that had prevented the creation of an effective vaccine in the ...

  22 July 2011 | Gus Cairns

• Novel vaccine did not protect monkeys against infection – but may have cured them

  A novel vaccine using the common virus Cytomegalovirus (CMV) as the vector or container of proteins from the simian immunodeficiency virus (SIV) protected none of a group of 24 rhesus macaques from infection. But in 13 of ...

  19 May 2011 | Gus Cairns

• Transmissible gene therapy treatment proposed for HIV to curb epidemic

  Engineered, virus-like particles that would latch onto HIV, exploit its genes, stop it from replicating and then get transmitted in the same way as HIV are being proposed as a new way of stopping the epidemic. Biochemist Leor Weinberger ...

  17 March 2011 | Keith Alcorn

• Gardasil safe and effective in young men

  The Gardasil vaccine prevents infection and disease associated with high-risk strains of human papilloma virus (HPV) in males, an international team of investigators report in the February 3rd edition of The New England Journal of Medicine. Sexually experienced boys and ...

  07 February 2011 | Michael Carter

• Flu vaccine recommendations for patients with HIV are 'justified'; vaccination encouraged

  Recommendations that patients with HIV should be vaccinated against influenza “are justified,” according to an editorial in the January 1st edition of Clinical Infectious Diseases, and the use of the vaccine “should be encouraged.” The author, Dr Raphael Dolin of ...

  07 January 2011 | Michael Carter

More news

Vaccines news selected from other sources

• Experts, Advocates Urge Continued Funding For Research Into HIV, TB Vaccines

  "[P]articipants at a symposium held last week by the U.K. Consortium on AIDS and International Development warned that [progress on HIV and tuberculosis (TB) vaccines] could be jeopardized by the recent downturn in global health funding," BMJ reports.

  23 May 2012 | Kaiser Daily Global Health Policy Report

• Newly discovered breast milk antibodies help neutralize HIV

  Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi.

  23 May 2012 | EurekAlert (press release)

• HIV Vaccine Awareness Day: A Statement from Anthony Fauci

  With an ongoing commitment to HIV vaccine research, we have the potential to radically change the trajectory of the HIV/AIDS pandemic.

  18 May 2012 | NIAID

• What ever happened to the Thai HIV vaccine?

  In 2009, it was announced that the first successful HIV vaccine, the Thai vaccine, had been identified. At the time, this news was greeted with both excitement and skepticism, but we haven’t heard much about it since. What happened to the vaccine? Why isn’t it available? Will it ever be?

  14 May 2012 | CATIE

• Study confirms early elevated HIV infection risk in some Step Study participants

  A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo.

  07 May 2012 | EurekAlert (press release)

• Shingles vaccine is safe, according to new study

  The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine.

  23 April 2012 | Eurekalert Medicine & Health

• Possible clues found to why HIV vaccine showed modest protection

  Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine.

  04 April 2012 | Eurekalert Inf Dis

• HIV 'superinfection' boosts immune response: Findings may provide insight into HIV-vaccine development

  Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody responses that block the replication of the virus compared to women who’ve only been infected once.

  30 March 2012 | Science Daily

• Inovio Pharmaceuticals' PENNVAX®-B HIV Vaccine Demonstrates Strong T-Cell Immune Responses in Therapeutic Vaccine Trial

  Significant T-cell responses against multiple HIV antigens demonstrate potential of Inovio's synthetic vaccines for HIV therapy.

  14 March 2012 | Manual Items

• Zostavax Shingles Vaccine Generally Safe, Increases Antibody Levels, in People With Stable HIV

  Two doses of Zostavax, a vaccine against shingles (herpes zoster), administered six weeks apart is “generally safe” for people living with HIV with CD4 counts of 200 or higher and undetectable viral loads, according to study results shared Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI).

  12 March 2012 | AIDSMeds

More news